Literature DB >> 16131924

Allergic reaction to topical eyedrops.

Christophe Baudouin1.   

Abstract

PURPOSE OF REVIEW: To examine recently published papers dealing with drug-induced allergic reactions. As allergy is only one possible mechanism, this review was extended to all reports or studies describing allergic, inflammatory or toxic effects related to eyedrops since 2004. RECENT
FINDINGS: These studies were first classified into clinical reports or surveys, experimental works and biological studies showing drug-induced effects on the ocular surface or eyelids. Studies aimed at determining the role of preservatives or comparing preservative-free and preserved eyedrops were further analysed separately.
SUMMARY: Reports on allergic or toxic reactions of eyedrops are published repeatedly. The reports raising the most important issues are those concerning antiglaucoma drugs. They consistently describe inflammatory reactions at the conjunctival level, with strong evidence that preservative is a major source of toxicity for the ocular surface.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16131924     DOI: 10.1097/01.all.0000183112.86181.9e

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  25 in total

1.  [Pharmacokinetics of the anterior eye].

Authors:  K Bell; N Pfeiffer; F H Grus
Journal:  Ophthalmologe       Date:  2014-02       Impact factor: 1.059

2.  Ocular surface evaluation in eyes with chronic glaucoma on long term topical antiglaucoma therapy.

Authors:  Manu Saini; Murugesan Vanathi; Tanuj Dada; Tushar Agarwal; Rebika Dhiman; Sudarshan Khokhar
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

Review 3.  Ocular surface - a complex and vulnerable adoptive environment for topical glaucoma treatment.

Authors:  Vasile Potop
Journal:  Rom J Ophthalmol       Date:  2016 Jul-Sep

Review 4.  Conjunctivitis: a systematic review of diagnosis and treatment.

Authors:  Amir A Azari; Neal P Barney
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

5.  A comfort comparison of travoprost BAK-free 0.004% versus latanoprost 0.005% in patients with primary open-angle glaucoma or ocular hypertension.

Authors:  David A Godfrey; Lee S Peplinski; Jeanette A Stewart; William C Stewart
Journal:  Clin Ophthalmol       Date:  2009-06-02

6.  The role of difluprednate ophthalmic emulsion in clinical practice.

Authors:  Karim N Jamal; David G Callanan
Journal:  Clin Ophthalmol       Date:  2009-06-29

7.  Anaphylactic response to topical fluorescein 2% eye drops: a case report.

Authors:  Humma Shahid; John F Salmon
Journal:  J Med Case Rep       Date:  2010-01-29

8.  Side effects of commonly used glaucoma medications: comparison of tolerability, chance of discontinuation, and patient satisfaction.

Authors:  Henny J M Beckers; Jan S A G Schouten; Carroll A B Webers; Rikkert van der Valk; Fred Hendrikse
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-06-25       Impact factor: 3.117

9.  Phospholipases A2 in normal human conjunctiva and from patients with primary open-angle glaucoma and exfoliation glaucoma.

Authors:  Minna Helin; Seppo Rönkkö; Tuomo Puustjärvi; Markku Teräsvirta; Hannu Uusitalo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-01-15       Impact factor: 3.117

Review 10.  Preservative-Free Prostaglandin Analogs and Prostaglandin/Timolol Fixed Combinations in the Treatment of Glaucoma: Efficacy, Safety and Potential Advantages.

Authors:  Gábor Holló; Andreas Katsanos; Kostas G Boboridis; Murat Irkec; Anastasios G P Konstas
Journal:  Drugs       Date:  2018-01       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.